|
|
| Research article summary (published 29 Sep 2009): |
Effects of levosimendan versus dobutamine on left atrial function in decompensated heart failure.
Full Abstract
BACKGROUND: Although the effects of levosimendan on the left ventricle (LV) have been studied, its effect on left atrial (LA) function is poorly understood, despite its key role in optimizing LV function. OBJECTIVE: To compare the effects of levosimendan and dobutamine on LA and LV function in patients with decompensated heart failure (DHF). METHODS: Seventy-four patients (mean [+/- SD] age 64+/-10 years) with DHF and an LV ejection fraction of 35% or lower were randomly assigned to receive levosimendan (n=37) or dobutamine (n=37). LA active emptying fraction, LA passive emptying fraction (PEF) and the ratio of mitral inflow early diastolic velocity to annulus velocity (E/e) were evaluated with pulsed wave and tissue Doppler imaging along with plasma B-type natriuretic peptide (BNP) level measurements before and after drug infusion. RESULTS: The ejection fraction was significantly increased in both groups. The levosimendan group had a greater decrease in BNP and a greater increase in active emptying fraction at 24 h compared with the dobutamine group. The PEF, E/e and deceleration time of the E wave were significantly improved in the levosimendan group, but not in the dobutamine group. Levosimendan- induced percentage change of BNP was significantly correlated with the percentage change of E/e and PEF (r=0.48 [P<0.005] and r=-0.38 [P<0.05], respectively). CONCLUSIONS: In patients with DHF, levosimendan and dobutamine both improve LV systolic function. However, levosimendan also improves LV diastolic function and LA performance in parallel with a greater improvement in neurohormonal activation compared with dobutamine.
Author information
Author/s: Duman, Duman (D); Palit, Fatih (F); Simsek, Ergun (E); Bilgehan, Karadag (K); Sacide, Atalay (A);
Affiliation: Department of Cardiology, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey. drduman(-atsign-)excite.com
Journal and publication information
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
Journal: The Canadian journal of cardiology (Can J Cardiol), published in Canada. (Language: eng)
Reference: 2009-Oct; vol 25 (issue 10) : pp e353-6
Dates: Created 2009/10/08; Completed 2009/10/27;
PMID: 19812809, status: MEDLINE (last retrieval date: 10/27/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Natriuretic peptide-guided levosimendan therapy for heart failure: a promising new approach.
19 May 2008 - A struggle to SURVIVE: to abandon or not to abandon levosimendan?
29 Sep 2007 - Cardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics.
19 Feb 2006 - The prolonged lowering effect of levosimendan on brain natriuretic peptide levels in patients with decompansated heart failure: clinical implications.
20 May 2008 - Patients with advanced heart failure and the effects of levosimendan.
24 Mar 2007 - Can we believe in levosimendan?
28 Feb 2008 - Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
4 May 2006 - [The novelty in the treatment of heart failure]
30 Dec 2004 - Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.
30 Dec 2007 - Improvement in Doppler alternans in patients with severe heart failure: Levosimendan versus dobutamin.
8 Apr 2007
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.